Researchers in the University of Minnesota College of Science and Engineering have developed a unique new device using the wonder material graphene that provides the first step toward ultrasensitive biosensors to detect diseases at the molecular level with near perfect efficiency.
Ultrasensitive biosensors for probing protein structures could greatly improve the depth of diagnosis for a wide variety of diseases extending to both humans and animals. These include Alzheimer’s disease, Chronic Wasting Disease, and mad cow disease—disorders related to protein misfolding. Such biosensors could also lead to improved technologies for developing new pharmaceutical compounds.
The research is published in Nature Nanotechnology, a peer-reviewed scientific journal published by Nature Publishing Group.
“In order to detect and treat many diseases we need to detect protein molecules at very small amounts and understand their structure,” said Sang-Hyun Oh, University of Minnesota electrical and computer engineering professor and lead researcher on the study. “Currently, there are many technical challenges with that process. We hope that our device using graphene and a unique manufacturing process will provide the fundamental research that can help overcome those challenges.”
Graphene, a material made of a single layer of carbon atoms, was discovered more than a decade ago. It has enthralled researchers with its range of amazing properties that have found uses in many new applications, including creating better sensors for detecting diseases.
Significant attempts have been made to improve biosensors using graphene, but the challenge exists with its remarkable single atom thickness. This means it does not interact efficiently with light when shined through it. Light absorption and conversion to local electric fields is essential for detecting small amounts of molecules when diagnosing diseases. Previous research utilizing similar graphene nanostructures has only demonstrated a light absorption rate of less than 10 percent.
In this new study, University of Minnesota researchers combined graphene with nano-sized metal ribbons of gold. Using sticky tape and a high-tech nanofabrication technique developed at the University of Minnesota, called “template stripping,” researchers were able to create an ultra-flat base layer surface for the graphene.
They then used the energy of light to generate a sloshing motion of electrons in the graphene, called plasmons, which can be thought to be like ripples or waves spreading through a “sea” of electrons. Similarly, these waves can build in intensity to giant “tidal waves” of local electric fields based on the researchers’ clever design.
By shining light on the single-atom-thick graphene layer device, they were able to create a plasmon wave with unprecedented efficiency at a near-perfect 94 percent light absorption into “tidal waves” of electric field. When they inserted protein molecules between the graphene and metal ribbons, they were able to harness enough energy to view single layers of protein molecules.
“Our computer simulations showed that this novel approach would work, but we were still a little surprised when we achieved the 94 percent light absorption in real devices,” said Oh, who holds the Sanford P. Bordeau Chair in Electrical Engineering at the University of Minnesota. “Realizing an ideal from a computer simulation has so many challenges. Everything has to be so high quality and atomically flat. The fact that we could obtain such good agreement between theory and experiment was quite surprising and exciting.”
Learn more: Research Brief: New graphene-based device is first step toward ultrasensitive biosensors
The Latest on: Biosensors
[google_news title=”” keyword=”biosensors” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Biosensors
- The best GPS running watches for every type of runneron May 8, 2024 at 8:39 am
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
- Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Developmenton May 8, 2024 at 3:36 am
DUBLIN, Ireland, May 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
- Researchers Add Chirality to Borophene, Opening the Door to Advanced Sensors and Implantable Medical Deviceson May 7, 2024 at 5:00 pm
“This study was just the beginning. We have several projects underway to develop biosensors, drug delivery systems and imaging applications for borophene.” Along with Pan, other authors of the study ...
- Wonder Material 'More Remarkable' Than Graphene Has Medical Potentialon May 7, 2024 at 8:55 am
Borophene is already thinner and more conductive than graphene, and scientists have altered it to make it even more special.
- 'Better than graphene' material development may improve implantable technologyon May 6, 2024 at 7:01 am
Move over, graphene. There's a new, improved two-dimensional material in the lab. Borophene, the atomically thin version of boron first synthesized in 2015, is more conductive, thinner, lighter, ...
- Biosensors Market Size To Touch USD 52.93 Billion, Rising At A CAGR Of 7.9% By 2030: SNS Insideron May 5, 2024 at 6:03 am
( MENAFN - Evertise Digital) - The Biosensors Market , valued at USD 28.80 billion in 2022, is forecasted to reach USD 52.93 billion by 2030, growing at a CAGR of 7.9% from 2023 to 2030.
- EECE.4410 Introduction to Biosensors (Formerly 16.441/541)on April 8, 2024 at 1:56 pm
This course introduces the theory and design of biosensors and their applications for pathology, pharmacogenetics, public health, food safety civil defense, and environmental monitoring. Optical, ...
- Affinity Biosensors of Santa Barbara receives FDA approval of LifeScale AST testing deviceon April 4, 2024 at 5:45 pm
SANTA BARBARA, Calif. – Affinity Biosensors of Santa Barbara announced Wednesday that the diagnostic company's LifeScale AST system has received clearance from the U.S. Food and Drug Administration.
- Affinity Biosensors Receives FDA Clearance for the LifeScale AST Systemon April 3, 2024 at 4:20 pm
SANTA BARBARA, Calif., April 3, 2024 /PRNewswire/ -- Affinity Biosensors, a leading innovator in the field of healthcare diagnostics, announces that its groundbreaking LifeScale AST system has ...
- The Shocking Biotech Applications Of Electric Bacteriaon June 24, 2019 at 8:50 pm
New research from scientists at the University of Massachusetts Amherst shows that pili—tiny filaments jutting out from bacteria—can be used to create wires used in biosensors and bioelectronics.
via Bing News